PAMJ Clinical Medicine (Nov 2019)

A rare case of a gestational and metastatic choriocarcinoma

  • Abderrahim Siati,
  • Imane Benmouna,
  • Anas Nah,
  • Amina Lakhdar,
  • Abdelaziz Baidada,
  • Aicha Kharbach

DOI
https://doi.org/10.11604/pamj-cm.2019.1.20.20958
Journal volume & issue
Vol. 1, no. 20

Abstract

Read online

Gestational choriocarcinoma is a malignant and rare trophoblastic tumor. It belongs to the group of gestational trophoblastic diseases (GTD) whose common denominator is hypersecretion of the gonadotrophic chorionic hormone. It is a highly malignant tumor made from the juxtaposition of cytotrophoblast and syncytiotrophoblast cells with complete disappearance of chorionic villi. It is most often metastatic and is followed in most cases by a hydatiform mole, but may also occur after spontaneous abortion or normal pregnancy. We present a case of a 50-year-old Moroccan patient, G2P2, admitted to the gynecological emergency department for vaginal bleeding and dyspnea. Speculum examination showed an invasive vaginal lesion. Thoracic-abdominal-pelvic CT showed bilateral pulmonary nodules and cystic lesions in the uterus and vagina. Through a vaginal biopsy, the diagnosis of choriocarcinoma was confirmed. Taking into account the usually very chemo-sensitive character of these diseases, EMA-CO type chemotherapy (Etoposide, Methotrexate and Actinomycin D alternating at weekly intervals with Vincristine and Cyclophosphamide) has been introduced. The patient received 8 cycles of EMA-CO including 2 cycles after normalization of β-hCG. The evolution was very favorable and regular controle was scheduled.

Keywords